Blueprint Medicines Corporation
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
508.67 |
721.41 |
953.93 |
1,175.42 |
1,431.15 |
1,632.29 |
| Przychód Δ r/r |
0.00% |
41.82% |
32.23% |
23.22% |
21.76% |
14.05% |
| Przychód (min) |
503.27 |
672.19 |
934.87 |
1,173.40 |
1,402.55 |
1,599.68 |
| Przychód (max) |
520.77 |
782.23 |
977.49 |
1,177.44 |
1,466.49 |
1,672.60 |
| EBITDA (średnia) |
-261.79 |
-371.28 |
-490.94 |
-604.94 |
-736.55 |
-840.07 |
| EBIT (średnia) |
-266.63 |
-378.14 |
-500.02 |
-616.12 |
-750.16 |
-855.60 |
| EBIT % |
-52.42% |
-52.42% |
-52.42% |
-52.42% |
-52.42% |
-52.42% |
| Zysk netto (średni) |
-64.60 |
-44.07 |
57.91 |
238.18 |
388.51 |
516.67 |
| Zysk netto % |
-12.70% |
-6.11% |
6.07% |
20.26% |
27.15% |
31.65% |
| EPS (średnia) |
-0.98 |
-0.70 |
0.92 |
3.65 |
6.18 |
8.22 |
| Liczba analityków (Przychody) |
15 |
5 |
10 |
15 |
6 |
11 |
| Liczba analityków (EPS) |
10 |
9 |
10 |
13 |
9 |
11 |
| symbol |
BPMC |
BPMC |
BPMC |
BPMC |
BPMC |
BPMC |